| Name | Title | Contact Details |
|---|
Alliance Physical Therapy Partners is the 7th largest physical therapy provider in the U.S., with more than 70 outpatient PT locations nationwide. The company was founded by patient-focused healthcare experts who were seeking to transform the traditional healthcare experience by infusing innovation and passion so that more people can enjoy the benefits of physical therapy. Alliance Physical Therapy Partners is also the parent company of Work-Fit, an injury prevention solutions provider who applies sports medicine techniques in the workplace to prevent injuries. In addition, BioCorrect Custom Orthotics Lab is part of the Alliance Physical Therapy Partner brands, providing a patented foot alignment system, evaluation process, and innovative custom and semi-custom foot orthotics for competitive athletics, outdoor recreation or people just living life to the fullest. Alliance Physical Therapy Partners is an affiliate of GPB Capital Holdings, LLC focused on acquiring private physical therapy practices across the U.S. to provide practice owners the opportunity to expand their footprint while receiving operational guidance and financial support. The Alliance team includes former private practice owners, direct marketing professionals and operations experts who have experience running and growing successful healthcare organizations. About GPB Capital Holdings, LLC GPB Capital is a New York-based alternative asset management firm focusing on acquiring income-producing private companies. GPB Capital seeks to provide its portfolio companies with the strategic planning, managerial insight, and capital needed to enable strong businesses to achieve the next level of growth and profitability. GPB Capital has over $1.5 billion in assets under management[i] and has acquired or invested in more than 160 portfolio companies. For more information, please visit www.gpb-cap.com. [i] Which is different and distinct from GPB Capital`s “Regulatory AUM.”
lcelyx was founded in 2010 with venture capital backing based on Gut Sensory Modulation (GSM) technology. Elcelyx`s proprietary, first-in-class Gut Sensory Modulators are delivered directly to the lower gut where they act on molecular targets to elicit physiological and pharmacological effects. The Elcelyx proprietary product candidate, NewMet for Type 2 diabetes is entering Phase 2b development and is a blockbuster opportunity designed to address the unmet needs in the oral anti-diabetic market. Elcelyx is led by an experienced management team and Board of Directors with track records of success in drug development and commercialization. Premier investors along with seasoned scientists and clinicians support the team. In September 2013, Elcelyx announced the formation of NaZura BioHealth Inc, a separate company established to focus on the development on non-NewMet assets.
Genysis Brand Solutions is a customer-centric, turn-key powder and capsule manufacturer.
Purity Life Health Products Limited is a Acton, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
ABK Biomedical Inc. combines a compelling clinical market need with innovative biomaterials invented by Drs. Bob Abraham, Daniel Boyd and Sharon Kehoe.